✦ LIBER ✦

Neoadjuvant Capecitabine and Oxaliplatin Followed by Synchronous Chemoradiation and Total Mesorectal Excision in Magnetic Resonance Imaging-Defined Poor-Risk Rectal Cancer

✍ Scribed by Chau, I.

Book ID: 127126165
Publisher: American Society of Clinical Oncology
Year: 2006
Tongue: English
Weight: 288 KB
Volume: 24
Category: Article
ISSN: 0732-183X
DOI: 10.1200/jco.2005.04.4875

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neoadjuvant capecitabine and oxaliplatin

Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial

✍ Yu Jo Chua; Yolanda Barbachano; David Cunningham; Jacqui R Oates; Gina Brown; An 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 115 KB

305 Twelve weeks of neoadjuvant capecita

305 Twelve weeks of neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation (CRT) and total mesorectal excision (TME) in MRI defined poor risk locally advanced rectal cancer resulted in promising tumour regression and rapid symptomatic relief

✍ I. Chau; D. Cunningham; D. Tait; G. Brown; N. Tebbutt; M. Hill; A. Wotherspoon; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 346 KB

Multicenter Randomized Phase II Clinical

Multicenter Randomized Phase II Clinical Trial Comparing Neoadjuvant Oxaliplatin, Capecitabine, and Preoperative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision in Patients With High-Risk Rectal Cancer (EXPERT-C)

✍ Dewdney, A.; Cunningham, D.; Tabernero, J.; Capdevila, J.; Glimelius, B.; Cervan 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 171 KB